Publication Name	World Journal of Gastroenterology
Manuscript ID	24371
Country	Brazil

Received	2016-01-21 13:30
Peer-Review Started	2016-01-21 17:08
To Make the First Decision	2016-02-18 11:47
Return for Revision	2016-02-19 13:45
Revised	2016-03-02 11:59
Second Decision	2016-03-11 08:04
Accepted by Journal Editor-in-Chief	2016-03-14 11:43
Accepted by Executive Editor-in-Chief	2016-03-30 16:48
Articles in Press	2016-03-30 16:50
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2016-04-06 12:24
Publish the Manuscript Online	2016-05-17 10:45

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Pathology
Manuscript Type	Topic Highlights
Article Title	HER2 testing in gastric cancer: An update
Manuscript Source	Invited Manuscript
All Author List	Lucas Faria Abrahao-Machado and Cristovam Scapulatempo-Neto
Funding Agency and Grant Number
Corresponding Author	Lucas Faria Abrahao-Machado, MD, Department of Pathology, Barretos Cancer Hospital, Rua Antenor Duarte Villela 1331, Barretos, SP 14784-400, Brazil. lucasfariamachado@yahoo.com
Key Words	Human epidermal growth factor receptor 2 testing; Gastric cancer; Immunohistochemistry; Scoring system; Trastuzumab
Core Tip	It is clear that human epidermal growth factor receptor 2 (HER2) protein over-expression and gene amplification are much more heterogeneous in gastric cancer compared to breast cancer. Gastric and gastroesophageal tumors require a unique im-munohistochemistry scoring system and interpretation expertise. We aimed to clarify the key differences in immunohistochemistry interpretation of gastric cancer, providing a practical update on HER2 testing and scoring.
Publish Date	2016-05-17 10:45
Citation	Abrahao-Machado LF, Scapulatempo-Neto C. HER2 testing in gastric cancer: An update. World J Gastroenterol 2016; 22(19): 4619-4625
URL	http://www.wjgnet.com/1007-9327/full/v22/i19/4619.htm
DOI	http://dx.doi.org/10.3748/wjg.v22.i19.4619

Full Article (PDF)	WJG-22-4619.pdf
Full Article (Word)	WJG-22-4619.doc
Manuscript File	24371-Review.doc
Answering Reviewers	24371-Answering reviewers.pdf
Audio Core Tip	24371-Audio core tip.3gp
Conflict-of-Interest Disclosure Form	24371-Conflict-of-interest statement.pdf
Copyright License Agreement	24371-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	24371-Language certificate.pdf
Peer-review Report	24371-Peer-review(s).pdf
Journal Editor-in-Chief Review Report	24371-Journal editor-in-chief review report.pdf
Scientific Misconduct Check	24371-Scientific misconduct check.pdf
Scientific Editor Work List	24371-Scientific editor work list.pdf